BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C
53 results:

  • 1. Undiagnosed RASopathies in infertile men.
    Juchnewitsch AG; Pomm K; Dutta A; Tamp E; Valkna A; Lillepea K; Mahyari E; Tjagur S; Belova G; Kübarsepp V; Castillo-Madeen H; Riera-Escamilla A; Põlluaas L; Nagirnaja L; Poolamets O; Vihljajev V; Sütt M; Versbraegen N; Papadimitriou S; McLachlan RI; Jarvi KA; Schlegel PN; Tennisberg S; Korrovits P; Vigh-Conrad K; O'Bryan MK; Aston KI; Lenaerts T; Conrad DF; Kasak L; Punab M; Laan M
    Front Endocrinol (Lausanne); 2024; 15():1312357. PubMed ID: 38654924
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of the RAF/MEK/ERK Signaling Cascade in pancreatic cancer: Recent Advances and Future Perspectives.
    Adamopoulos C; Cave DD; Papavassiliou AG
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338909
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multiple medicinal chemistry strategies of targeting KRAS: State-of-the art and future directions.
    Shang Y; Fu S; Hao Q; Ying H; Wang J; Shen T
    Bioorg Chem; 2024 Mar; 144():107092. PubMed ID: 38271825
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Unveiling the role of KRAS in tumor immune microenvironment.
    Xu M; Zhao X; Wen T; Qu X
    Biomed Pharmacother; 2024 Feb; 171():116058. PubMed ID: 38171240
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of a Novel, Potent, and Orally Bioavailable Guanidine-Based shp2 Allosteric Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of KRAS Mutant cancers.
    Hou Q; Jiang W; Li W; Huang C; Yang K; Chen X; Huang M; Shu C; Luo G; Sun H; Chu Q; Wu X
    J Med Chem; 2023 Oct; 66(19):13646-13664. PubMed ID: 37754066
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. shp2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
    Drilon A; Sharma MR; Johnson ML; Yap TA; Gadgeel S; Nepert D; Feng G; Reddy MB; Harney AS; Elsayed M; Cook AW; Wong CE; Hinklin RJ; Jiang Y; Brown EN; Neitzel NA; Laird ER; Wu WI; Singh A; Wei P; Ching KA; Gaudino JJ; Lee PA; Hartley DP; Rothenberg SM
    Cancer Discov; 2023 Aug; 13(8):1789-1801. PubMed ID: 37269335
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies.
    Khan S; Budamagunta V; Zhou D
    Adv Cancer Res; 2023; 159():145-184. PubMed ID: 37268395
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Major Venous Repair or Reconstruction During Laparoscopic pancreatic Surgery: A Single Center's Experience.
    Jie Z; Zhou X; Haibiao W; Ying D; Chen B; Li H
    J Laparoendosc Adv Surg Tech A; 2023 Sep; 33(9):890-896. PubMed ID: 37074117
    [No Abstract]    [Full Text] [Related]  

  • 10. miR-6071 inhibits hepatocellular carcinoma progression via targeting ptpn11.
    Chen M; Wang H; Shi S; Zhang H; Xu S; Jiang Y
    Arch Biochem Biophys; 2022 Sep; 727():109345. PubMed ID: 35792156
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Human Norovirus Triggers Primary B Cell Immune Activation
    Mirabelli C; Jones MK; Young VL; Kolawole AO; Owusu I; Shan M; Abuaita B; Turula H; Trevino JG; Grigorova I; Lundy SK; Lyssiotis CA; Ward VK; Karst SM; Wobus CE
    mBio; 2022 Apr; 13(2):e0017522. PubMed ID: 35404121
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Structure-based discovery of a specific shp2 inhibitor with enhanced blood-brain barrier penetration from PubChem database.
    Ma Y; Li WY; Sun T; Zhang L; Lu XH; Yang B; Wang RL
    Bioorg Chem; 2022 Apr; 121():105648. PubMed ID: 35180489
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic significance of shp2 (ptpn11) expression in solid tumors: A meta-analysis.
    Zhou J; Guo H; Zhang Y; Liu H; Dou Q
    PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis.
    Khan I; Marelia-Bennet C; Lefler J; Zuberi M; Denbaum E; Koide A; Connor DM; Broome AM; Pécot T; Timmers C; Ostrowski MC; Koide S; O'Bryan JP
    Small GTPases; 2022 Jan; 13(1):114-127. PubMed ID: 33949915
    [No Abstract]    [Full Text] [Related]  

  • 15. Novel regulation of Ras proteins by direct tyrosine phosphorylation and dephosphorylation.
    Buday L; Vas V
    Cancer Metastasis Rev; 2020 Dec; 39(4):1067-1073. PubMed ID: 32936431
    [TBL] [Abstract] [Full Text] [Related]  

  • 16.
    Valencia-Sama I; Ladumor Y; Kee L; Adderley T; Christopher G; Robinson CM; Kano Y; Ohh M; Irwin MS
    Cancer Res; 2020 Aug; 80(16):3413-3423. PubMed ID: 32586982
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Defining and Targeting Adaptations to Oncogenic KRAS
    Santana-Codina N; Chandhoke AS; Yu Q; Małachowska B; Kuljanin M; Gikandi A; Stańczak M; Gableske S; Jedrychowski MP; Scott DA; Aguirre AJ; Fendler W; Gray NS; Mancias JD
    Cell Rep; 2020 Mar; 30(13):4584-4599.e4. PubMed ID: 32234489
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta-analysis.
    Tacelli M; Celsa C; Magro B; Barchiesi M; Barresi L; Capurso G; Arcidiacono PG; Cammà C; Crinò SF
    Dig Endosc; 2020 Nov; 32(7):1018-1030. PubMed ID: 31912580
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. shp2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors.
    Lu H; Liu C; Velazquez R; Wang H; Dunkl LM; Kazic-Legueux M; Haberkorn A; Billy E; Manchado E; Brachmann SM; Moody SE; Engelman JA; Hammerman PS; Caponigro G; Mohseni M; Hao HX
    Mol Cancer Ther; 2019 Jul; 18(7):1323-1334. PubMed ID: 31068384
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation.
    Kano Y; Gebregiworgis T; Marshall CB; Radulovich N; Poon BPK; St-Germain J; Cook JD; Valencia-Sama I; Grant BMM; Herrera SG; Miao J; Raught B; Irwin MS; Lee JE; Yeh JJ; Zhang ZY; Tsao MS; Ikura M; Ohh M
    Nat Commun; 2019 Jan; 10(1):224. PubMed ID: 30644389
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.